Editorial: Publishing in 2023 and Beyond

I am excited to introduce myself as the new editor in chief of Current Therapeutic Research (CTR). I became involved in CTR as a reviewer and board member in 2014. I am thrilled to be taking on the role of editor in chief for CTR and to be involved with a journal that is open access and peer-reviewed. CTR focuses on research covering the entire spectrum of therapeutics, from medications to interventions and from discoveries to applications. Before expanding, I would like to recognize Dr Philip Walson for his long service as CTR's editor in chief. It will be hard to follow in the footsteps of someone who invested so much in CTR over the years and grew the Journal with his tireless efforts. Finally, thank you, Dr Walson, for staying involved as editor in chief emeritus.